BioPsychoSocial Health | By April 07, 2006 | By Shaheen E Lakhan, MS, MEd, PhDcloseShaheen E Lakhan, MS, MEd, PhD Name: Shaheen Lakhan
Site: http://slakhan.gnif.org
See All Articles by Author (104)
About: Dr. Lakhan is the Executive Director of the Global Neuroscience Initiative Foundation (GNIF). He administers a host of projects in bioethics, biotechnology, emergency management, global philanthropy, proteomics, and psychiatry -- to name a few disciplines. | 11 Comments

Integrating Schizophrenia Management

Schizophrenia treatment has significantly evolved since Nobel Laureate John Nash was initially treated with electro-convulsive therapy (ECT) and insulin coma “therapies” in the 50-60’s — as portrayed in the movie, A Beautiful Mind. Now, the ultimate goals of schizophrenia clinical management are to reduce or eliminate all associated symptoms, improve socio-behavioral functioning, foster reintegration into society, prevent the relapse of psychotic episodes, and treat or prevent (further) co-morbidity. Clinicians employ a combination of pharmacological (neuroleptic) and psychosocial interventions according to the vulnerability-stress-coping model. The first line of coping is usually medicinal options for the suppression of symptoms and control of disturbed behavior. Psychosocial modalities contribute to improve patient insight and compliance, while promoting the development and implementation of personal goals. Read more →